浓度依赖性血浆蛋白结合在丙吡胺处置中的作用。 - Suppr

Suppr

超能文献

Role of concentration-dependent plasma protein binding in disopyramide disposition.

作者信息

Meffin P J, Robert E W, Winkle R A, Harapat S, Peters F A, Harrison D C

出版信息

J Pharmacokinet Biopharm. 1979 Feb;7(1):29-46. doi: 10.1007/BF01059439.

DOI:10.1007/BF01059439

PMID:458555

Abstract

摘要

相似文献

Role of concentration-dependent plasma protein binding in disopyramide disposition.浓度依赖性血浆蛋白结合在丙吡胺处置中的作用。

J Pharmacokinet Biopharm. 1979 Feb;7(1):29-46. doi: 10.1007/BF01059439.

Plasma binding of disopyramide.丙吡胺的血浆结合

Br J Clin Pharmacol. 1980 Jun;9(6):614-8. doi: 10.1111/j.1365-2125.1980.tb01090.x.

The influence of blood collection technique on serum and plasma protein binding of disopyramide.采血技术对丙吡胺血清和血浆蛋白结合的影响。

Eur J Clin Pharmacol. 1982;22(2):185-9. doi: 10.1007/BF00542466.

Concentration-dependence of disopyramide binding to plasma protein and its influence on kinetics and dynamics.丙吡胺与血浆蛋白结合的浓度依赖性及其对动力学和动力学的影响。

J Pharmacol Exp Ther. 1981 Dec;219(3):741-7.

Comparative binding of disopyramide phosphate and quinidine sulfate to human plasma proteins.磷酸丙吡胺和硫酸奎尼丁与人血浆蛋白的结合比较

J Pharm Sci. 1974 Dec;63(12):1877-9. doi: 10.1002/jps.2600631210.

Plasma protein binding of disopyramide by equilibrium dialysis and ultrafiltration.通过平衡透析和超滤法测定丙吡胺的血浆蛋白结合率。

Ther Drug Monit. 1983;5(1):81-6. doi: 10.1097/00007691-198303000-00007.

Protein binding and erythrocyte partitioning of disopyramide and its monodealkylated metabolite.丙吡胺及其单脱烷基代谢物的蛋白质结合和红细胞分配

J Pharm Sci. 1974 Nov;63(11):1684-90. doi: 10.1002/jps.2600631103.

Determination of unbound fraction of disopyramide in plasma: a comparison of equilibrium dialysis, ultrafiltration through dialysis membranes and ultrafree anticonvulsant drug filters.血浆中丙吡胺游离分数的测定：平衡透析、通过透析膜超滤及使用抗惊厥药物超滤过滤器的比较

J Pharmacol Methods. 1982 Jan;7(1):7-14. doi: 10.1016/0160-5402(82)90053-5.

Plasma binding of disopyramide and mono-N-dealkyldisopyramide.丙吡胺及单-N-去烷基丙吡胺的血浆结合情况。

Br J Clin Pharmacol. 1982 Nov;14(5):673-6. doi: 10.1111/j.1365-2125.1982.tb04955.x.

Disopyramide plasma concentrations following single and multiple doses of the immediate- and controlled-release capsules.单次及多次服用速释和控释胶囊后丙吡胺的血浆浓度。

Angiology. 1983 Jun;34(6):375-92. doi: 10.1177/000331978303400602.

引用本文的文献

Gut microbiota and cardiac arrhythmia: a pharmacokinetic scope.肠道微生物群与心律失常：药代动力学视角

Egypt Heart J. 2022 Dec 30;74(1):87. doi: 10.1186/s43044-022-00325-2.

Assessment of an In Silico Mechanistic Model for Proarrhythmia Risk Prediction Under the CiPA Initiative.基于 CiPA 倡议的致心律失常风险预测的计算机制模型评估。

Clin Pharmacol Ther. 2019 Feb;105(2):466-475. doi: 10.1002/cpt.1184. Epub 2018 Aug 27.

Therapeutic drug monitoring of antiarrhythmic drugs.抗心律失常药物的治疗药物监测

Clin Pharmacokinet. 2003;42(7):647-63. doi: 10.2165/00003088-200342070-00004.

Therapeutic drug monitoring: antiarrhythmic drugs.治疗药物监测：抗心律失常药物

Br J Clin Pharmacol. 1998 Oct;46(4):307-19. doi: 10.1046/j.1365-2125.1998.t01-1-00768.x.

Adverse effects of class I antiarrhythmic drugs.I类抗心律失常药物的不良反应。

Drug Saf. 1997 Jul;17(1):8-36. doi: 10.2165/00002018-199717010-00002.

Pharmacokinetics of oral disopyramide phosphate in patients with renal impairment.肾功能损害患者口服磷酸丙吡胺的药代动力学。

Br J Clin Pharmacol. 1980 Sep;10(3):245-8. doi: 10.1111/j.1365-2125.1980.tb01751.x.

Modeling of drug response in individual subjects.个体受试者药物反应的建模。

J Pharmacokinet Biopharm. 1980 Apr;8(2):115-30. doi: 10.1007/BF01065188.

Plasma binding of disopyramide.丙吡胺的血浆结合

Br J Clin Pharmacol. 1980 Jun;9(6):614-8. doi: 10.1111/j.1365-2125.1980.tb01090.x.

Comparative bioavailability of disopyramide after multiple dosing with standard capsules and controlled-release tablets.丙吡胺标准胶囊与控释片多次给药后的生物利用度比较

Eur J Clin Pharmacol. 1980;17(3):209-13. doi: 10.1007/BF00561902.

Plasma concentrations and protein binding of disopyramide and mono-N-dealkyldisopyramide during chronic oral disopyramide therapy.慢性口服丙吡胺治疗期间丙吡胺及单-N-去烷基丙吡胺的血浆浓度和蛋白结合率

Br J Clin Pharmacol. 1981 Apr;11(4):369-75. doi: 10.1111/j.1365-2125.1981.tb01134.x.

本文引用的文献

Observations on the antirheumatic and physiologic effects of phenylbutazone (butazolidin) and some comparisons with cortisone.关于保泰松（布他唑立丁）的抗风湿及生理效应的观察以及与可的松的某些比较

Am J Med. 1954 Feb;16(2):181-90. doi: 10.1016/0002-9343(54)90333-2.

Binding of anilide-type local anesthetics in human plasma. I. Relationships between binding, physicochemical properties, and anesthetic activity.酰苯胺类局部麻醉药在人血浆中的结合。I. 结合、物理化学性质与麻醉活性之间的关系。

Anesthesiology. 1970 Sep;33(3):287-303. doi: 10.1097/00000542-197009000-00002.

Nonlinear plasma level response to high doses of naproxen.高剂量萘普生的非线性血浆水平反应。

Clin Pharmacol Ther. 1974 Mar;15(3):261-6. doi: 10.1002/cpt1974153261.

Statistical estimations in pharmacokinetics.药物动力学中的统计学估计

J Pharmacokinet Biopharm. 1974 Apr;2(2):123-48. doi: 10.1007/BF01061504.

A safe method for rapidly achieving plasma concentration plateaus.一种快速达到血浆浓度平台期的安全方法。

Clin Pharmacol Ther. 1974 Oct;16(4):691-700. doi: 10.1002/cpt1974164691.

Disopyramide phosphate: pharmacokinetic and pharmacologic relationships of a new antiarrhythmic agent.磷酸丙吡胺：一种新型抗心律失常药物的药代动力学和药理学关系。

Arch Int Pharmacodyn Ther. 1971 May;191(1):162-88.

Binding of drugs to serum albumin (first of two parts).药物与血清白蛋白的结合（两部分中的第一部分）

N Engl J Med. 1976 Feb 5;294(6):311-6. doi: 10.1056/NEJM197602052940605.

The pharmacokinetics of Norpace.心律平的药代动力学。

Angiology. 1975 Jan;26(1 Pt 2):85-98.

Anti-arrhythmic and haemodynamic effects of intravenous and oral disopyramide in patients with ventricular arrhythmia.

J Int Med Res. 1976;4(1 Suppl):90-5.

Correlation of disopyramide pharmacokinetics with efficacy in ventricular tachyarrhythmia.丙吡胺的药代动力学与室性快速心律失常疗效的相关性。

J Int Med Res. 1976;4(1 Suppl):54-8.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验